Publications from OUS - Breast tumor evolution (Sørlie)

107 publications found

Publications 2024

1. Cun HT, Bernard L, Lande KT, Lawson BC, Nesbakken AJ, Davidson B, Lindemann K, Fellman B, Sørlie T, Soliman PT, Eriksson AGZ (2024)
   Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma
   Gynecol Oncol, 189, 138-145
   DOI 10.1016/j.ygyno.2024.07.677, PubMed 39126895
2. Davidson B, Teien Lande K, Nebdal D, Nesbakken AJ, Holth A, Lindemann K, Zahl Eriksson AG, Sørlie T (2024)
   Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
   Virchows Arch (in press)
   DOI 10.1007/s00428-024-03912-7, PubMed 39235515
3. Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman JL, López-Plana A, Bergholtz H, Noguera-Castells A, Del Burgo PJ, Chen X, Sorlie T, Gascón P, Bragado P, Bissell M, Carbó N, Fuster G (2024)
   The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma
   Breast Cancer Res, 26 (1), 122
   DOI 10.1186/s13058-024-01871-0, PubMed 39138514
4. Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GA et al. (2024)
   Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)
   ESMO Open, 9 (6), 103475
   DOI 10.1016/j.esmoop.2024.103475, PubMed 38838499

Publications 2023

1. Haugen MH, von der Lippe Gythfeldt H, Egeland EV, Svartdal Normann L, Pandya AD, Vedin LL, Juell S, Tenstad E, Øy GF, Kristian A, Marangoni E, Sørlie T, Steffensen K, Maelandsmo GM, Engebraaten O (2023)
   Liver X receptors induce antiproliferative effects in basal-like breast cancer
   Mol Oncol, 17 (10), 2041-2055
   DOI 10.1002/1878-0261.13476, PubMed 37341140
2. Połeć A, Ekstrøm PO, Fougner C, Sørlie T, Norum JH (2023)
   Rapid assessment of 3-dimensional intra-tumor heterogeneity through cycling temperature capillary electrophoresis
   BMC Res Notes, 16 (1), 167
   DOI 10.1186/s13104-023-06437-5, PubMed 37568187
3. van Amerongen R, Bentires-Alj M, van Boxtel AL, Clarke RB, Fre S, Suarez EG, Iggo R, Jechlinger M, Jonkers J, Mikkola ML, Koledova ZS, Sørlie T, Vivanco MD (2023)
   Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research
   J Mammary Gland Biol Neoplasia, 28 (1), 17
   DOI 10.1007/s10911-023-09544-y, PubMed 37450065

Publications 2022

1. Bergholtz H, Lien T, Lingaas F, Sørlie T (2022)
   Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
   J Mammary Gland Biol Neoplasia, 27 (2), 171-183
   DOI 10.1007/s10911-022-09523-9, PubMed 35932380
2. Langille E, Al-Zahrani KN, Ma Z, Liang M, Uuskula-Reimand L, Espin R, Teng K, Malik A, Bergholtz H, Ghamrasni SE, Afiuni-Zadeh S, Tsai R, Alvi S, Elia A, Lü Y, Oh RH, Kozma KJ, Trcka D, Narimatsu M, Liu JC, Nguyen T, Barutcu S, Loganathan SK, Bremner R, Bader GD et al. (2022)
   Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
   Cancer Discov, 12 (12), 2930-2953
   DOI 10.1158/2159-8290.CD-21-0865, PubMed 36108220
3. Staaf J, Häkkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I, Lien T, Sørlie T, Naume B, Russnes H, Marcone R, Ayyanan A, Brisken C, Malterling RR, Asking B, Olofsson H, Lindman H, Bendahl PO, Ehinger A, Larsson C, Loman N, Rydén L, Malmberg M, Borg Å, Vallon-Christersson J (2022)
   RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
   NPJ Breast Cancer, 8 (1), 94
   DOI 10.1038/s41523-022-00465-3, PubMed 35974007

Publications 2021

1. Bergholtz H, Carter JM, Cesano A, Cheang MCU, Church SE, Divakar P, Fuhrman CA, Goel S, Gong J, Guerriero JL, Hoang ML, Hwang ES, Kuasne H, Lee J, Liang Y, Mittendorf EA, Perez J, Prat A, Pusztai L, Reeves JW, Riazalhosseini Y, Richer JK, Sahin Ö, Sato H, Schlam I et al. (2021)
   Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx^® Digital Spatial Profiler
   Cancers (Basel), 13 (17)
   DOI 10.3390/cancers13174456, PubMed 34503266
2. Lien TG, Ohnstad HO, Lingjærde OC, Vallon-Christersson J, Aaserud M, Sveli MAT, Borg Å, Osbreac OBO, Garred Ø, Borgen E, Naume B, Russnes H, Sørlie T (2021)
   Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
   Cancers (Basel), 13 (23)
   DOI 10.3390/cancers13236118, PubMed 34885228
3. Lilleborge M, Falk RS, Sørlie T, Ursin G, Hofvind S (2021)
   Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion
   Int J Cancer, 149 (6), 1247-1256
   DOI 10.1002/ijc.33680, PubMed 33990967
4. Lingjærde C, Lien TG, Borgan Ø, Bergholtz H, Glad IK (2021)
   Tailored graphical lasso for data integration in gene network reconstruction
   BMC Bioinformatics, 22 (1), 498
   DOI 10.1186/s12859-021-04413-z, PubMed 34654363
5. Oksvold MP, Berglund UW, Gad H, Bai B, Stokke T, Rein ID, Pham T, Sanjiv K, Øy GF, Norum JH, Smeland EB, Myklebust JH, Helleday T, Våtsveen TK (2021)
   Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma
   Sci Rep, 11 (1), 6317
   DOI 10.1038/s41598-021-85613-8, PubMed 33737576
6. Xu H, Lien T, Bergholtz H, Fleischer T, Djerroudi L, Vincent-Salomon A, Sørlie T, Aittokallio T (2021)
   Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression
   Front Genet, 12, 670749
   DOI 10.3389/fgene.2021.670749, PubMed 34149812

Publications 2020

1. Bergholtz H, Kumar S, Wärnberg F, Lüders T, Kristensen V, Sørlie T (2020)
   Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
   Cancer Rep (Hoboken), 3 (3), e1248
   DOI 10.1002/cnr2.1248, PubMed 32671987
2. Bergholtz H, Lien TG, Swanson DM, Frigessi A, Oslo Breast Cancer Research Consortium (OSBREAC), Daidone MG, Tost J, Wärnberg F, Sørlie T (2020)
   Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
   NPJ Breast Cancer, 6, 26
   DOI 10.1038/s41523-020-0167-x, PubMed 32577501
3. Engelsen AST, Wnuk-Lipinska K, Bougnaud S, Pelissier Vatter FA, Tiron C, Villadsen R, Miyano M, Lotsberg ML, Madeleine N, Panahandeh P, Dhakal S, Tan TZ, Peters SD, Grøndal S, Aziz SM, Nord S, Herfindal L, Stampfer MR, Sørlie T, Brekken RA, Straume O, Halberg N, Gausdal G, Thiery JP, Akslen LA et al. (2020)
   AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer
   iScience, 23 (11), 101649
   DOI 10.1016/j.isci.2020.101649, PubMed 33103086
4. Fougner C, Bergholtz H, Norum JH, Sørlie T (2020)
   Re-definition of claudin-low as a breast cancer phenotype
   Nat Commun, 11 (1), 1787
   DOI 10.1038/s41467-020-15574-5, PubMed 32286297
5. Knutsen E, Lellahi SM, Aure MR, Nord S, Fismen S, Larsen KB, Gabriel MT, Hedberg A, Bjørklund SS, Oslo Breast Cancer Research Consortium (OSBREAC), Bofin AM, Mælandsmo GM, Sørlie T, Mortensen ES, Perander M (2020)
   The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
   Sci Rep, 10 (1), 1277
   DOI 10.1038/s41598-020-57759-4, PubMed 31992741
6. von der Lippe Gythfeldt H, Lien T, Tekpli X, Silwal-Pandit L, Borgen E, Garred Ø, Skjerven H, Schlichting E, Lundgren S, Wist E, Naume B, Kristensen V, Børresen-Dale AL, Lingjaerde OC, Engebraaten O (2020)
   Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer
   Int J Cancer, 147 (9), 2515-2525
   DOI 10.1002/ijc.33108, PubMed 32488909

Publications 2019

1. Bergholtz H, Lien TG, Ursin G, Holmen MM, Helland Å, Sørlie T, Haakensen VD (2019)
   A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue
   J Mammary Gland Biol Neoplasia, 24 (2), 163-175
   DOI 10.1007/s10911-018-09423-x, PubMed 30613869
2. Fougner C, Bergholtz H, Kuiper R, Norum JH, Sørlie T (2019)
   Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers
   Breast Cancer Res, 21 (1), 85
   DOI 10.1186/s13058-019-1170-8, PubMed 31366361
3. Norum JH, Frings O, Kasper M, Bergholtz H, Zell Thime H, Bergström Å, Andersson A, Kuiper R, Fredlund E, Sørlie T, Toftgård R (2019)
   GLI1-induced mammary gland tumours are transplantable and maintain major molecular features
   Int J Cancer, 146 (4), 1125-1138
   DOI 10.1002/ijc.32522, PubMed 31219615
4. Swanson DM, Lien T, Bergholtz H, Sørlie T, Frigessi A (2019)
   A Bayesian two-way latent structure model for genomic data integration reveals few pan-genomic cluster subtypes in a breast cancer cohort
   Bioinformatics, 35 (23), 4886-4897
   DOI 10.1093/bioinformatics/btz381, PubMed 31077301
5. Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø, OSBREAC, Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN (2019)
   An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
   Nat Commun, 10 (1), 5499
   DOI 10.1038/s41467-019-13329-5, PubMed 31796750

Publications 2018

1. Norum JH, Skarpen E, Brech A, Kuiper R, Waaler J, Krauss S, Sørlie T (2018)
   The tankyrase inhibitor G007-LK inhibits small intestine LGR5⁺ stem cell proliferation without altering tissue morphology
   Biol Res, 51 (1), 3
   DOI 10.1186/s40659-017-0151-6, PubMed 29316982

Publications 2017

1. Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E et al. (2017)
   Interrogating open issues in cancer precision medicine with patient-derived xenografts
   Nat Rev Cancer, 17 (4), 254-268
   DOI 10.1038/nrc.2016.140, PubMed 28104906
2. Byrne AT, Alférez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinská E, Caldas C, Chang DK, Clarke RB, Clevers H, Coukos G, Dangles-Marie V, Eckhardt SG, Gonzalez-Suarez E, Hermans E, Hidalgo M, Jarzabek MA, de Jong S, Jonkers J, Kemper K, Lanfrancone L, Mælandsmo GM, Marangoni E et al. (2017)
   Interrogating open issues in cancer medicine with patient-derived xenografts
   Nat Rev Cancer, 17 (10), 632 (in press)
   DOI 10.1038/nrc.2017.85, PubMed 28912576
3. Gil Del Alcazar CR, Huh SJ, Ekram MB, Trinh A, Liu LL, Beca F, Zi X, Kwak M, Bergholtz H, Su Y, Ding L, Russnes HG, Richardson AL, Babski K, Min Hui Kim E, McDonnell CH, Wagner J, Rowberry R, Freeman GJ, Dillon D, Sorlie T, Coussens LM, Garber JE, Fan R, Bobolis K et al. (2017)
   Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition
   Cancer Discov, 7 (10), 1098-1115
   DOI 10.1158/2159-8290.CD-17-0222, PubMed 28652380
4. Laurberg T, Tramm T, Nielsen T, Alsner J, Nord S, Myhre S, Sørlie T, Leung S, Fan C, Perou C, Gelmon K, Overgaard J, Voduc D, Prat A, Cheang MCU (2017)
   Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials
   Acta Oncol, 57 (1), 38-43
   DOI 10.1080/0284186X.2017.1401735, PubMed 29172851
5. Ohnstad HO, Borgen E, Falk RS, Lien TG, Aaserud M, Sveli MAT, Kyte JA, Kristensen VN, Geitvik GA, Schlichting E, Wist EA, Sørlie T, Russnes HG, Naume B (2017)
   Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
   Breast Cancer Res, 19 (1), 120
   DOI 10.1186/s13058-017-0911-9, PubMed 29137653
6. Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL et al. (2017)
   The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer
   Clin Cancer Res, 23 (16), 4662-4670
   DOI 10.1158/1078-0432.CCR-17-0160, PubMed 28487444

Publications 2016

1. Halvorsen AR, Silwal-Pandit L, Meza-Zepeda LA, Vodak D, Vu P, Sagerup C, Hovig E, Myklebost O, Børresen-Dale AL, Brustugun OT, Helland Å (2016)
   TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
   Front Genet, 7, 85
   DOI 10.3389/fgene.2016.00085, PubMed 27242894
2. Lesurf R, Aure MR, Mørk HH, Vitelli V, Oslo Breast Cancer Research Consortium (OSBREAC), Lundgren S, Børresen-Dale AL, Kristensen V, Wärnberg F, Hallett M, Sørlie T (2016)
   Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
   Cell Rep, 16 (4), 1166-1179
   DOI 10.1016/j.celrep.2016.06.051, PubMed 27396337
3. Sørlie T (2016)
   The Impact of Gene Expression Patterns in Breast Cancer
   Clin Chem, 62 (8), 1150-1
   DOI 10.1373/clinchem.2015.253229, PubMed 27022070

Publications 2015

1. Borgquist S, Zhou W, Jirström K, Amini RM, Sollie T, Sørlie T, Blomqvist C, Butt S, Wärnberg F (2015)
   The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
   BMC Cancer, 15, 468
   DOI 10.1186/s12885-015-1479-3, PubMed 26062614
2. Norum JH, Bergström Å, Andersson AB, Kuiper RV, Hoelzl MA, Sørlie T, Toftgård R (2015)
   A conditional transgenic mouse line for targeted expression of the stem cell marker LGR5
   Dev Biol, 404 (2), 35-48
   DOI 10.1016/j.ydbio.2015.05.002, PubMed 26003047
3. Potapenko IO, Lüders T, Russnes HG, Helland Å, Sørlie T, Kristensen VN, Nord S, Lingjærde OC, Børresen-Dale AL, Haakensen VD (2015)
   Glycan-related gene expression signatures in breast cancer subtypes; relation to survival
   Mol Oncol, 9 (4), 861-76
   DOI 10.1016/j.molonc.2014.12.013, PubMed 25655580
4. Skrbo N, Tenstad E, Mælandsmo GM, Sørlie T, Andersen K (2015)
   From autonomy to community; new perspectives on tumorigenicity and therapy resistance
   Cancer Treat Rev, 41 (10), 809-13
   DOI 10.1016/j.ctrv.2015.10.004, PubMed 26519005

Publications 2014

1. Grinde MT, Skrbo N, Moestue SA, Rødland EA, Borgan E, Kristian A, Sitter B, Bathen TF, Børresen-Dale AL, Mælandsmo GM, Engebraaten O, Sørlie T, Marangoni E, Gribbestad IS (2014)
   Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
   Breast Cancer Res, 16 (1), R5
   DOI 10.1186/bcr3597, PubMed 24447408
2. Norum JH, Andersen K, Sørlie T (2014)
   Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy
   Br J Surg, 101 (8), 925-38
   DOI 10.1002/bjs.9562, PubMed 24849143
3. Skrbo N, Hjortland GO, Kristian A, Holm R, Nord S, Prasmickaite L, Engebraaten O, Mælandsmo GM, Sørlie T, Andersen K (2014)
   Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft
   PLoS One, 9 (11), e113278
   DOI 10.1371/journal.pone.0113278, PubMed 25419568
4. Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL (2014)
   Mutation screening of the TP53 gene by temporal temperature gel electrophoresis (TTGE)
   Methods Mol Biol, 1105, 315-24
   DOI 10.1007/978-1-62703-739-6_25, PubMed 24623239
5. Tramm T, Kyndi M, Myhre S, Nord S, Alsner J, Sørensen FB, Sørlie T, Overgaard J (2014)
   Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer
   Acta Oncol, 53 (10), 1337-46
   DOI 10.3109/0284186X.2014.925580, PubMed 24957550
6. Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Børresen-Dale AL, Sørlie T, Frigessi A, Overgaard J (2014)
   Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort
   Clin Cancer Res, 20 (20), 5272-80
   DOI 10.1158/1078-0432.CCR-14-0458, PubMed 25149560
7. Zhao X, Rødland EA, Sørlie T, Vollan HK, Russnes HG, Kristensen VN, Lingjærde OC, Børresen-Dale AL (2014)
   Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
   BMC Cancer, 14, 211
   DOI 10.1186/1471-2407-14-211, PubMed 24645668

Publications 2013

1. Myhre S, Lingjærde OC, Hennessy BT, Aure MR, Carey MS, Alsner J, Tramm T, Overgaard J, Mills GB, Børresen-Dale AL, Sørlie T (2013)
   Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins
   Mol Oncol, 7 (3), 704-18
   DOI 10.1016/j.molonc.2013.02.018, PubMed 23562353
2. Tramm T, Hennig G, Kyndi M, Alsner J, Sørensen FB, Myhre S, Sørlie T, Overgaard J (2013)
   Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection
   Virchows Arch, 463 (6), 775-86
   DOI 10.1007/s00428-013-1486-1, PubMed 24100522
3. Zhou W, Jirström K, Amini RM, Fjällskog ML, Sollie T, Lindman H, Sørlie T, Blomqvist C, Wärnberg F (2013)
   Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
   BMC Cancer, 13, 512
   DOI 10.1186/1471-2407-13-512, PubMed 24171825

Publications 2012

1. Borgan E, Lindholm EM, Moestue S, Mælandsmo GM, Lingjærde OC, Gribbestad IS, Børresen-Dale AL, Engebraaten O, Sørlie T (2012)
   Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts
   Mol Oncol, 7 (1), 130-42
   DOI 10.1016/j.molonc.2012.10.005, PubMed 23142657
2. Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, Van de Vijver M, Viale G, Loi S, Reis-Filho JS (2012)
   Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
   Ann Oncol, 23 (12), 2997-3006
   DOI 10.1093/annonc/mds586, PubMed 23166150
3. Kim J, Villadsen R, Sørlie T, Fogh L, Grønlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H, Edwards PA, Børresen-Dale AL, Rønnov-Jessen L, Bissell MJ, Petersen OW (2012)
   Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
   Proc Natl Acad Sci U S A, 109 (16), 6124-9
   DOI 10.1073/pnas.1203203109, PubMed 22454501

Publications 2011

1. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
   Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
   Mol Oncol, 5 (6), 564-76
   DOI 10.1016/j.molonc.2011.08.004, PubMed 21917534
2. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland Å, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL (2011)
   Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
   Proc Natl Acad Sci U S A, 109 (8), 2802-7
   DOI 10.1073/pnas.1108781108, PubMed 21908711
3. Sørlie T (2011)
   How to personalise treatment in early breast cancer
   Eur J Cancer, 47 Suppl 3, S310-1
   DOI 10.1016/S0959-8049(11)70182-4, PubMed 21943994
4. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC (2011)
   Combining gene signatures improves prediction of breast cancer survival
   PLoS One, 6 (3), e17845
   DOI 10.1371/journal.pone.0017845, PubMed 21423775

Publications 2010

1. Borgan E, Sitter B, Lingjærde OC, Johnsen H, Lundgren S, Bathen TF, Sørlie T, Børresen-Dale AL, Gribbestad IS (2010)
   Merging transcriptomics and metabolomics--advances in breast cancer profiling
   BMC Cancer, 10, 628
   DOI 10.1186/1471-2407-10-628, PubMed 21080935
2. Børresen-Dale AL, Sørlie T, Kristensen VN (2010)
   On the molecular biology of breast cancer
   Mol Oncol, 4 (3), 171-3
   DOI 10.1016/j.molonc.2010.04.007, PubMed 20483673
3. Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F (2010)
   Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
   Mol Oncol, 4 (4), 357-68
   DOI 10.1016/j.molonc.2010.06.007, PubMed 20663721
4. Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J (2010)
   Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
   Breast Cancer Res, 12 (1), R3
   DOI 10.1186/bcr2466, PubMed 20056007
5. Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T (2010)
   In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome
   PLoS One, 5 (11), e14002
   DOI 10.1371/journal.pone.0014002, PubMed 21124964
6. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
   Mol. Oncol., 4 (2), 169
   DOI 10.1016/j.molonc.2010.01.003
7. Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sørlie T, Tagliabue E, Børresen-Dale AL, FEMME Consortium (2010)
   Triple-negative breast cancer: present challenges and new perspectives
   Mol Oncol, 4 (3), 209-29
   DOI 10.1016/j.molonc.2010.04.006, PubMed 20537966
8. Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
   Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
   Sci Transl Med, 2 (38), 38ra47
   DOI 10.1126/scitranslmed.3000611, PubMed 20592421
9. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, Nilsen G, Lingjaerde OC, Børresen-Dale AL, Rødland E (2010)
   The importance of gene-centring microarray data
   Lancet Oncol, 11 (8), 719-20; author reply 720-1
   DOI 10.1016/S1470-2045(10)70174-1, PubMed 20688275

Publications 2009

1. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT (2009)
   Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
   Clin Cancer Res, 15 (11), 3654-62
   DOI 10.1158/1078-0432.CCR-08-3293, PubMed 19470724
2. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
   Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
   Mol Oncol, 3 (5-6), 469-82
   DOI 10.1016/j.molonc.2009.07.003, PubMed 19713161
3. Muggerud AA, Edgren H, Wolf M, Kleivi K, Dejeux E, Tost J, Sørlie T, Kallioniemi O (2009)
   Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
   BMC Med Genomics, 2, 26
   DOI 10.1186/1755-8794-2-26, PubMed 19432969
4. Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale AL (2009)
   Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
   Mol Oncol, 4 (2), 98-118
   DOI 10.1016/j.molonc.2009.12.001, PubMed 20060370
5. Sørlie T (2009)
   Introducing molecular subtyping of breast cancer into the clinic?
   J Clin Oncol, 27 (8), 1153-4
   DOI 10.1200/JCO.2008.20.6276, PubMed 19204193
6. Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A (2009)
   Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
   Mol Oncol, 3 (3), 214-9
   DOI 10.1016/j.molonc.2009.03.001, PubMed 19403344

Publications 2008

1. Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J (2008)
   A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients
   Acta Oncol, 47 (4), 600-7
   DOI 10.1080/02841860802047411, PubMed 18465328
2. Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL (2008)
   Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
   J Pathol, 214 (3), 357-67
   DOI 10.1002/path.2278, PubMed 18044827
3. Nordgard SH, Alnaes GI, Hihn B, Lingjaerde OC, Liestøl K, Tsalenko A, Sørlie T, Lønning PE, Børresen-Dale AL, Kristensen VN (2008)
   Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival
   Int J Cancer, 123 (3), 577-85
   DOI 10.1002/ijc.23541, PubMed 18498133
4. Suspitsin EN, Due EU, Vu P, Hirvonen A, Børresen-Dale AL, Imyanitov EN (2008)
   TP53 mutations in synchronous and metachronous bilateral breast carcinomas
   Cancer Genet Cytogenet, 184 (2), 119-21
   DOI 10.1016/j.cancergencyto.2008.03.005, PubMed 18617062

Publications 2007

1. Edvardsen H, Tefre T, Jansen L, Vu P, Haffty BG, Fosså SD, Kristensen VN, Børresen-Dale AL (2007)
   Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
   Radiat Oncol, 2, 25
   DOI 10.1186/1748-717X-2-25, PubMed 17623063
2. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
   Mol Oncol, 1 (2), 160-71
   DOI 10.1016/j.molonc.2007.03.004, PubMed 19383292
3. Sørlie T (2007)
   Molecular classification of breast tumors: toward improved diagnostics and treatments
   Methods Mol Biol, 360, 91-114
   DOI 10.1385/1-59745-165-7:91, PubMed 17172726

Publications 2006

1. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR (2006)
   Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
   Genes Chromosomes Cancer, 45 (11), 1033-40
   DOI 10.1002/gcc.20366, PubMed 16897746
2. Kristensen VN, Edvardsen H, Tsalenko A, Nordgard SH, Sørlie T, Sharan R, Vailaya A, Ben-Dor A, Lønning PE, Lien S, Omholt S, Syvänen AC, Yakhini Z, Børresen-Dale AL (2006)
   Genetic variation in putative regulatory loci controlling gene expression in breast cancer
   Proc Natl Acad Sci U S A, 103 (20), 7735-40
   DOI 10.1073/pnas.0601893103, PubMed 16684880
3. Muggerud AA, Johnsen H, Barnes DA, Steel A, Lønning PE, Naume B, Sørlie T, Børresen-Dale AL (2006)
   Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes
   BMC Cancer, 6, 59
   DOI 10.1186/1471-2407-6-59, PubMed 16536878
4. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL (2006)
   Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
   BMC Genomics, 7, 127
   DOI 10.1186/1471-2164-7-127, PubMed 16729877

Publications 2005

1. Andressen KW, Norum JH, Levy FO, Krobert KA (2005)
   Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression
   Mol Pharmacol, 69 (1), 207-15
   DOI 10.1124/mol.105.015396, PubMed 16189297
2. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ (2005)
   Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
   Proc Natl Acad Sci U S A, 102 (10), 3738-43
   DOI 10.1073/pnas.0409462102, PubMed 15701700
3. Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
   Clin Cancer Res, 11 (2 Pt 2), 878s-83s
   PubMed 15701881
4. Kristensen VN, Sørlie T, Geisler J, Yoshimura N, Linegjaerde OC, Glad I, Frigessi A, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer
   J Steroid Biochem Mol Biol, 95 (1-5), 105-11
   DOI 10.1016/j.jsbmb.2005.04.028, PubMed 16023338
5. Lønning PE, Sørlie T, Børresen-Dale AL (2005)
   Genomics in breast cancer-therapeutic implications
   Nat Clin Pract Oncol, 2 (1), 26-33
   DOI 10.1038/ncponc0072, PubMed 16264853
6. Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL (2005)
   Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis
   Methods Mol Biol, 291, 207-16
   DOI 10.1385/1-59259-840-4:207, PubMed 15502225
7. Wolf M, Edgren H, Muggerud A, Kilpinen S, Huusko P, Sorlie T, Mousses S, Kallioniemi O (2005)
   NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer
   Cell. Oncol., 27 (3), 169-173
8. Wolf M, Edgren H, Muggerud A, Kilpinen S, Huusko P, Sørlie T, Mousses S, Kallioniemi O (2005)
   NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer
   Cell Oncol, 27 (3), 169-73
   DOI 10.1155/2005/478316, PubMed 16037637

Publications 2004

1. Sørlie T (2004)
   Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
   Eur J Cancer, 40 (18), 2667-75
   DOI 10.1016/j.ejca.2004.08.021, PubMed 15571950
2. Troester MA, Hoadley KA, Sørlie T, Herbert BS, Børresen-Dale AL, Lønning PE, Shay JW, Kaufmann WK, Perou CM (2004)
   Cell-type-specific responses to chemotherapeutics in breast cancer
   Cancer Res, 64 (12), 4218-26
   DOI 10.1158/0008-5472.CAN-04-0107, PubMed 15205334

Publications 2003

1. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO et al. (2003)
   Gene expression patterns in ovarian carcinomas
   Mol Biol Cell, 14 (11), 4376-86
   DOI 10.1091/mbc.e03-05-0279, PubMed 12960427

Publications 2002

1. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AL, Brown PO (2002)
   Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
   Proc Natl Acad Sci U S A, 99 (20), 12963-8
   DOI 10.1073/pnas.162471999, PubMed 12297621

Publications 2001

1. Forus A, Sørlie T, Børresen-Dale AL, Myklebost O (2001)
   [Microarray technology--potential in cancer research]
   Tidsskr Nor Laegeforen, 121 (21), 2498-503
   PubMed 11875927
2. Lønning PE, Sørlie T, Perou CM, Brown PO, Botstein D, Børresen-Dale AL (2001)
   Microarrays in primary breast cancer--lessons from chemotherapy studies
   Endocr Relat Cancer, 8 (3), 259-63
   DOI 10.1677/erc.0.0080259, PubMed 11566617
3. Ostvold AC, Norum JH, Mathiesen S, Wanvik B, Sefland I, Grundt K (2001)
   Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo
   Eur J Biochem, 268 (8), 2430-40
   DOI 10.1046/j.1432-1327.2001.02120.x, PubMed 11298763
4. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL (2001)
   Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
   Proc Natl Acad Sci U S A, 98 (19), 10869-74
   DOI 10.1073/pnas.191367098, PubMed 11553815

Publications 2000

1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000)
   Molecular portraits of human breast tumours
   Nature, 406 (6797), 747-52
   DOI 10.1038/35021093, PubMed 10963602

Publications 1999

1. Berner JM, Sørlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brøgger A, Myklebost O, Lothe RA (1999)
   Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway
   Genes Chromosomes Cancer, 26 (2), 151-60
   DOI 10.1002/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A, PubMed 10469453

Publications 1998

1. Sørlie T, Andersen TI, Bukholm I, Børresen-Dale AL (1998)
   Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases
   Breast Cancer Res Treat, 48 (3), 259-64
   DOI 10.1023/a:1005953519972, PubMed 9598872
2. Sørlie T, Bukholm I, Børresen-Dale AL (1998)
   Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas. Mutations in brief no. 179. Online
   Hum Mutat, 12 (3), 215
   PubMed 10660330
3. Sørlie T, Martel-Planche G, Hainaut P, Lewalter J, Holm R, Børresen-Dale AL, Montesano R (1998)
   Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines
   Br J Cancer, 77 (10), 1573-9
   DOI 10.1038/bjc.1998.259, PubMed 9635831

Publications 1995

1. Esteve A, Sørlie T, Martel-Planche G, Hollstein M, Kusters I, Lewalter J, Vineis P, Stephan-Odenthal M, Montesano R (1995)
   Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors
   J Occup Environ Med, 37 (1), 59-68
   DOI 10.1097/00043764-199501000-00009, PubMed 7620944

Publications 1994

1. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC (1994)
   Database of p53 gene somatic mutations in human tumors and cell lines
   Nucleic Acids Res, 22 (17), 3551-5
   PubMed 7937055